Simple and reliable HPLC method of abacavir determination in pharmaceuticals, human serum and drug dissolution studies from tablets

Journal of Liquid Chromatography and Related Technologies

Volumn 28, Issue 3, 2005, Pages 423-437

  Özkan, Yalçin ^a   Savaşer, Ayhan ^a   Özkan, Sibel A ^b  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

^b ANKARA UNIVERSITY   (Turkey)

Author keywords

Abacavir determination; Drug dissolution study; Human serum; Pharmaceutical dosage form

Indexed keywords

ALCOHOLS; BIOASSAY; BODY FLUIDS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MEDICAL IMAGING; PH EFFECTS;

KETOPROFEN; PHARMACEUTICAL DOSAGE; SERUM; TIME-CONSUMING EXTRACTION;

DRUG PRODUCTS;

ABACAVIR; ACETONITRILE; KETOPROFEN; METHANOL; POTASSIUM DIHYDROGEN PHOSPHATE;

ACIDITY; ARTICLE; DEVICE; DRUG DETERMINATION; DRUG SOLUBILITY; DRUG STRUCTURE; EVAPORATION; FLOW RATE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; RELIABILITY; SERUM; STANDARD; TIME; VALIDATION PROCESS;

EID: 14544269452     PISSN: 10826076     EISSN: None     Source Type: Journal    
DOI: 10.1081/JLC-200044523     Document Type: Article

References (26)

1. Physicians Desk Reference (PDR), 56th Ed.; Medical Economics Company Inc.: Montvale, NJ, 2003; 1664.
2. Sweetman, S.C. Martindale, The Complete Drug Reference, 33th Ed.; Sweetman, S.C., Ed.; Pharmaceutical Press: London, 2002; 612.
3. Veldkamp, A.I.; Sparidans, R.W.; Hoetelmans, R.M.W.; Beijnen, J.H. Quantitative determination of abacavir (1592U89), a novel nucleoside reverse transcriptase inhibitor, in human plasma using isocratic reversed-phase high-performance liquid chromatography with ultraviolet detection. J. Chromatogr. B 1999, 736, 123-128.
4. Aymard, G.; Legrand, M.; Trichereau, N.; Diquet, B. Determination of twelve antiretroviral agents in human plasma sample using reversed-phase high-performance liquid chromatography. J. Chromatogr. B 2000, 744, 227-240.
5. Sparidans, R.W.; Hoetelmans, R.M.W.; Beijnen, J.H. Liquid chromatographic assay for simultaneous determination of abacavir and mycophenolic acid in human plasma using dual spectrophotometric detection. J. Chromatogr. B 2001, 750, 155-161.
6. Rezk, N.L.; Tidwell, R.R.; Kashuba, A.D.M. Simultaneous determination of six HIV nucleoside analogue reverse transcriptase inhibitors and nevirapine by liquid chromatography with ultraviolet absorbance detection. J. Chromatogr. B 2003, 791, 137-147.
7. Fung, E.N.; Cai, Z.; Burnette, T.C.K.; Sinhababu, A. Simultaneous determination of ziagen and its phosphorylated metabolites by ion-pairing high-performance liquid chromatography-tandem mass spectrometry. J. Chromatogr. B 2001, 754, 285-295.
8. Uslu, B.; Özkan, S.A. Anodic voltammetry of abacavir and its determination in pharmaceuticals and biological fluids. Electrochim. Acta 2004, 49, 4321-4329.
9. Rowe, S.R.; Carless, J.E. Comparison at the in vitro behaviour of various indomethacin formulations with their in vivo bioavailability. J. Pharm. Pharmacol. 1981, 33, 561-565.
10. Anchisi, C.; Baroli, B.M.; Fadda, A.M.; Manconi, M.; Sinico, C.; Valenti, D. Dissolution properties of flurazepam capsules. Farmaco 1998, 53, 662-666.
11. Özkan, Y.; Özkan, S.A.; Aboul-Enein, H.Y. Determination of clenbuterol HCl in human serum and pharmaceuticals and drug dissolution studies by RP-HPLC. J. Liq. Chromatogr. Relat. Technol. 2001, 24, 679-691.
12. Özkan, S.A.; Özkan, Y.; Aboul-Enein, H.Y. Quality control and drug dissolution studies of pharmaceutical preparations containing cerivastatin sodium by RP-HPLC. J. Liq. Chromatogr. Relat. Technol. 2002, 25, 251-262.
13. Satiropoulus, B.; Deutsch, T.; Plakogiannis, F.M. Comparative bioavailability of three commercial acetaminophen tablets. J. Pharm. Sci. 1981, 70, 422-425.
14. UsIu, B.; Özkan, S.A. Determination of lamivudine and zidovudine in binary mixture using first derivative spectrophotometric, first derivative of the ratio spectra and HPLC-UV methods. Anal. Chim. Acta 2002, 466, 175-185.
15. Özkan, S.A.; Uslu, B. A rapid HPLC assay for the determination of lamivudine in pharmaceuticals and human serum. J. Liq. Chromatogr. Relat. Technol. 2002, 25, 1447-1456.
16. Özkan, Y.; Savaşer, A.; Taş, Ç.; Uslu, B.; Özkan, S.A. Drug dissolution studies and determination of deflazacort in pharmaceutical formulation and human serum samples by RP-HPLC. J. Liq. Chromatogr. Relat. Technol. 2003, 26, 2141-2156.
17. Savaşer, A.; Özkan, C.K.; Özkan, Y.; Uslu, B.; Özkan, S.A. Development and validation of a RP-HPLC method for the determination of valacyclovir in tablets and human serum and its application to the drug dissolution studies. J. Liq. Chromatogr. Relat. Technol. 2003, 26, 1755-1767.
18. Riley, C.M.; Roosanske, T. W. Development and Validation of Analytical Methods; Elsevier Science Ltd.: New York, 1996.
19. Swartz, M.E.; Krull, I.S. Analytical Development and Validation; Marcel Dekker, Inc.: New York, 1997.
20. The United States Pharmacopoeia, The USP 24th Ed.; Easton, Rand Mc Nally: Taunton, MA, 2000 [CD-ROM].
21. Cheah, P.Y.; Yuen, K.H.; Liong, M.L. Improved high performance liquid chromatographic analysis of terazosin in human plasma. J. Chromatogr. B 2000, 745, 439-443.
22. Farrar, H.; Letzig, L.; Gill, H. Validation of a liquid chromatographic method for the determination of ibuprofen in human plasma. J. Chromatogr. B 2002, 780, 341-348.
23. Higuchi, T. Mechanism of sustained action medication. J. Pharm. Sci. 1963, 52, 1145-1149.
24. Langenbucher, F. Parametric representation of dissolution rate curves by the RRSBW distribution. Pharm. Ind. 1976, 38, 472-477.
25. Krosmeyer, R.W.; Gurny, R.; Doelker, E.; Buri, P.; Peppas, N.A. Mechanisms of solute release from porous hydrophilic polymers. Int. J. Pharm. 1983, 75, 25-35.
26. Ritger, P.L.; Peppas, N.A. A simple equation for description of solute release I. Fickian and non-Fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs. J. Controll. Release 1987, 5, 23-36.